MedPath

Comparing soft drink vs Carbex for double contrast upper GI studies

Not Applicable
Completed
Conditions
Oral and Gastrointestinal
Digestive System
Registration Number
ISRCTN75939860
Lead Sponsor
South Devon Healthcare NHS Foundation Trust (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
200
Inclusion Criteria

1. Any patient referred for an upper GI double contrast GI study and is able to give informed consent.
2. Include any patient over 18 not classified to belonging to a vulnerable group. No upper age limit

Exclusion Criteria

1. Aged below 18 years of age.
2. Unable to give consent
3. Member of vulnerable group

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Is the experimental soft drink used for gaseous distension of the upper GI tract not inferior to the gold standard Carbex against delta at study clinic?<br>2. Does the experimental soft drink provide a diagnostic upper GI double contrast barium study when used in the place of Carbex at study clinic?
Secondary Outcome Measures
NameTimeMethod
1. If the soft drink effervescent agent is found to be noninferior then a superiority test will be performed to ascertain whether it is better than Carbex.<br>2. What are the potential cost savings of using the soft drink over Carbex within this institution and nationwide?<br>Both assessed at the study clinic
© Copyright 2025. All Rights Reserved by MedPath